Merck & Co to buy Afferent for neurology drugs
Monday, June 13, 2016 - 09:10
in Psychology & Sociology
Deal worth up to $1.25bn includes drug candidate for chronic coughs
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via